Italy's Steel Tubing Dumped Cheap, Commerce Rules
Published Date: 9/16/2026
Notice
Summary
The U.S. Department of Commerce (Commerce) determines that Dalmine S.p.A. (Dalmine) made sales of subject merchandise at prices below normal value (NV) during the period of review (POR). The POR is June 1, 2024, through May 31, 2025.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Dalmine Assigned 68.95% Dumping Margin
The Department of Commerce found that Dalmine S.p.A. sold cold-drawn mechanical tubing from Italy at below-normal prices and assigned a weighted-average dumping margin of 68.95% for the period June 1, 2024 through May 31, 2025. This margin is based on adverse facts available (AFA) and is the official rate Commerce adopted in the final results.
CBP To Assess 68.95% Duties
U.S. Customs and Border Protection (CBP) will assess antidumping duties at an ad valorem rate of 68.95% on all appropriate entries of the subject merchandise from Dalmine during June 1, 2024 through May 31, 2025. Commerce intends to issue assessment instructions to CBP no earlier than 35 days after publication (September 16, 2026), and if a timely summons is filed, CBP will be instructed not to liquidate relevant entries until the statutory injunction period (within 90 days of publication) has expired.
Cash Deposit Rates Set After Publication
For shipments of cold-drawn mechanical tubing from Italy entered or withdrawn for consumption on or after the publication date (September 16, 2026), Commerce set the cash deposit rate for Dalmine equal to the 68.95% dumping margin. The notice also states the all-others rate remains 47.87% ad valorem and company-specific rates from prior segments continue to apply where relevant.
Importer Certificate Must Be Filed
Importers are reminded they must file a certificate about reimbursement of antidumping and/or countervailing duties prior to liquidation of relevant entries during the period June 1, 2024 through May 31, 2025. If importers fail to file this certificate, Commerce may presume reimbursement occurred and assess double antidumping duties.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18925, Chlorinated Isocyanurates From the People's Republic of China: Preliminary Results, and Rescission, in Part of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce (Commerce) preliminarily determines that chlorinated isocyanurates from the People's Republic of China (China) were sold in the United States at less than normal value during the period of review (POR) June 1, 2024, through May 31, 2025. Interested parties are invited to comment on these preliminary results.
2026-18940, Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules From Indonesia: Final Affirmative Countervailing Duty Determination and Final Affirmative Determination of Critical Circumstances, in Part
The U.S. Department of Commerce found that Indonesian makers of solar cells got unfair government help from January to December 2024. Because of this, extra taxes (called countervailing duties) will be added to these solar cells starting September 16, 2026. This means U.S. buyers might pay more, and Indonesian exporters will face new costs.
2026-18922, Certain Crystalline Silicon Photovoltaic Products From Taiwan: Final Results of the Antidumping Duty Administrative Review: 2024-2025
The U.S. Department of Commerce (Commerce) determines that EEPV Corp. (EEPV) did not sell subject merchandise in the United States at prices below normal value (NV) during the period of review (POR), February 1, 2024, through January 31, 2025.
2026-18947, Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules, From India: Final Affirmative Countervailing Duty Determination and the Final Affirmative Critical Circumstances Determination, in Part
The U.S. Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of crystalline silicon photovoltaic cells, whether or not assembled into modules (solar cells) from India. The period of investigation is April 1, 2024, through March 31, 2025.
2026-18935, UChicago Argonne LLC. et al.; Notice of Decision on Application for Duty-Free Entry of Scientific Instruments
UChicago Argonne LLC and several top research groups got the green light to bring in high-tech scientific instruments without paying import taxes because no equal tools are made in the U.S. This decision helps speed up important science projects by saving money and cutting red tape. No public objections were raised, so these duty-free entries are officially approved and ready to roll.
2026-18939, Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules, From Indonesia: Final Affirmative Determination of Sales at Less Than Fair Value and Final Affirmative Determination of Critical Circumstances
The U.S. Department of Commerce (Commerce) determines that imports of crystalline silicon photovoltaic cells, whether or not assembled into modules (solar cells) from Indonesia are being, or are likely to be, sold in the United States at less than fair value (LTFV). The period of investigation (POI) is July 1, 2024, through June 30, 2025.
Previous / Next Documents
Previous: 2026-18920, Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Pathogen-Agnostic Sequencing
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Microbiology Devices Panel of the Medical Devices Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA. In addition, the Committee will meet to discuss and provide advice to FDA on examining the scientific, clinical, and public health dimensions of the use of pathogen-agnostic sequencing as it relates to emergency preparedness and response efforts, and to support discussion of opportunities, implementation considerations, and potential priorities for future coordination. The preparedness use could cover local and national outbreaks, known pathogens, or unknown pathogens. This meeting is being held to satisfy, in part, a requirement under the Food and Drug Omnibus Reform Act of 2022 (FDORA). The meeting will be open to the public. FDA is establishing a docket for public comment.
Next: 2026-18922, Certain Crystalline Silicon Photovoltaic Products From Taiwan: Final Results of the Antidumping Duty Administrative Review: 2024-2025
The U.S. Department of Commerce (Commerce) determines that EEPV Corp. (EEPV) did not sell subject merchandise in the United States at prices below normal value (NV) during the period of review (POR), February 1, 2024, through January 31, 2025.